Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
MRI of the liver test tubes


Work Strand 5 focuses on serum biomarkers

Published research suggests there are a large number of biological factors predictive of Hepatitis C treatment outcome or disease progression.

The objective of this Work Strand is to generate serum biomarker datasets associated with treatment response and cirrhosis progression.

This Work Strand is led by Professor Will Irving (University of Nottingham).